Securities code: 000423 securities abbreviation: Dong-E-E-Jiao Co.Ltd(000423) Announcement No.: 2022-08 Dong-E-E-Jiao Co.Ltd(000423)
Annual performance forecast for 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Expected performance of the current period
1. Performance forecast period: January 1, 2021 to December 31, 2021
2. Expected performance: □ loss □ turning loss into profit √ rising in the same direction □ falling in the same direction
The current reporting period of the project is the same period of last year
Profit attributable to listed companies: 427.5 million yuan – 474.75 million yuan
Net profit of shareholders: 43.2893 million yuan, an increase of 888% – 997% over the same period of last year
Profit after deducting non recurring losses: 345.07 million yuan – 383.21 million yuan
Net profit loss after profit: 39.4621 million yuan, an increase of 974% – 1071% over the same period of last year
Basic earnings per share: 0.66 yuan / share – 0.74 yuan / share earnings: 0.07 yuan / share
2、 Communication with accounting firms
The relevant data of this performance forecast is the preliminary calculation result of the company’s financial department and has not been audited by an accounting firm. The company has conducted pre communication with the annual report audit accounting firm on matters related to the performance forecast, and the two sides have no differences on the performance forecast in this reporting period.
3、 Explanation of performance change reasons
The company insists on taking consumers as the center, focusing on customer growth and retention, accelerating product innovation, strengthening the transformation of scientific research achievements, constantly releasing brand productivity and realizing stable and benign growth.
In the future, the company will actively respond to the call of the state to promote the inheritance, innovation and development of traditional Chinese medicine, adhere to the guidance of becoming a “large health enterprise most trusted by consumers in the field of Chinese nourishing health”, and speed up the digital transformation and business model innovation guided by the needs of customers; Further promote “value remodeling, business remodeling, organization remodeling and spirit remodeling”, consolidate the market leadership of core products, extend the existing brand categories, provide solutions around the market and customer needs, improve the organizational ability of digital transformation, and promote the high-quality development of the company. 4、 Other relevant instructions
1. This performance forecast data is the result of preliminary calculation and has not been audited by an accounting firm. The specific financial data shall be subject to the 2021 annual report disclosed by the company.
2. The information disclosure media designated by the company are securities times, China Securities News, Shanghai Securities News and cninfo (www.cn. Info. Com. CN.), All information of the company shall be subject to the announcement published in the above media. Please make careful decisions and pay attention to investment risks.
It is hereby announced.
Board of directors
January 27, 2002
